This review is a summary of the use of methylprednisolone aceponate for atopic eczema.
It covers disease prevalence and diagnosis, treatment options and compliance, pharmacological properties, dosage and administration, funding criteria and some key papers looking at the use of this medication.
It also provides commentary and recommendations from Dr. Warren Weightman, current Head of the Department of Dermatology at the Queen Elizabeth Hospital, Adelaide and a Senior Lecturer with Adelaide University.
Please login below to download this issue (PDF)